Skip to main content

Table 2 Univariate logistic regression analysis for the prediction of high on-clopidogrel platelet reactivity (PRI VASP ≥61 %)

From: Impaired P2Y12 inhibition by clopidogrel in kidney transplant recipients: results from a cohort study

Variable OR CI (95 %) p
Age (years) 0.98 0.96–1.00 0.15
Sex (male) 1.63 0.85–3.14 0.15
Diabetes mellitus 1.54 0.80–2.96 0.20
Body mass index (kg/m2) 1.08 1.01–1.15 0.02
Hypertension 1.94 0.72–5.26 0.19
Tobacco 1.18 0.63–2.22 0.61
Dyslipidemia 1.93 0.83–4.50 0.13
eGFR (mL/min/1.73 m2) 0.99 0.98–1.00 0.09
CRP (mg/dL) 0.99 0.97–1.00 0.09
Kidney transplantation 2.61 1.22–5.55 0.01
Calcineurin inhibitors use 3.15 1.41–7.02 0.005
Anti-metabolites use 1.94 0.87–4.31 0.11
Proton pump inhibitor use 1.15 0.58–2.29 0.69
  1. Abbreviations: PRI platelet reactivity index, VASP vasodilator-stimulated phosphoprotein, OR odds ratio, CI confidence interval, eGFR estimated glomerular filtration rate, CRP C-reactive protein